Zooporu

Zooporu
©2009-2014 WWW.ELABINFO.COM ALL RIGHTS RESERVED.

Sort by Relevance Sort by Most Influenced Papers Sort by Citation Count Sort by Recency
Trends in usage of cytoreductive partial nephrectomy and effect on overall survival in patients with metastatic renal cell carcinoma.
Partial nephrectomy in the setting of metastatic renal cell carcinoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Partial nephrectomy seems to confer a survival benefit relative to radical nephrectomy in metastatic renal cell carcinoma.
Comparison of cytoreductive partial versus radical nephrectomy in metastatic renal cell carcinoma: To be on the horns of a dilemma
Is there a role for partial nephrectomy in patients with metastatic renal cell carcinoma?
Do renal cell carcinoma patients with brain metastases still need nephrectomy?
International Urology and Nephrology
Partial nephrectomy in the setting of metastatic renal cell carcinoma.
Individualised Indications for Cytoreductive Nephrectomy: Which Criteria Define the Optimal Candidates?
Cytoreductive nephrectomy for metastatic RCC in the era of targeted therapy
Partial nephrectomy for metastatic renal cell carcinoma: Where do we stand?
Indian journal of urology : IJU : journal of the Urological Society of India
View 6 excerpts, cites background and methods
SORT BY Relevance Most Influenced Papers Recency
Cytoreductive nephrectomy in patients with metastatic renal cancer: a combined analysis.
View 1 excerpt, references background
Cytoreductive nephrectomy for T4NxM1 renal cell carcinoma: the M.D. Anderson Cancer Center experience.
Cytoreductive nephrectomy in the elderly patient: the M. D. Anderson Cancer Center experience.
View 1 excerpt, references background
The role of nephron sparing surgery for metastatic (pM1) renal cell carcinoma.
Cytoreductive nephron‐sparing surgery does not appear to undermine disease‐specific survival in patients with metastatic renal cell carcinoma
The role of nephron‐sparing surgery (NSS) showed promise in patients with metastatic renal cell carcinoma (MRCC). The disease‐specific survival of patients with MRCC was compared according to the … Expand
Racial disparity in outcomes of a clinical trial population with metastatic renal cell carcinoma.
Tumor size improves the accuracy of TNM predictions in patients with renal cancer.
Multi-institutional validation of a symptom based classification for renal cell carcinoma.
Disparities in treatment and outcome for renal cell cancer among older black and white patients.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Multi-institutional validation of a new renal cancer-specific survival nomogram.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Stay Connected With Semantic Scholar
Collaborators & Attributions • Terms of Service • Privacy Policy
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy , Terms of Service , and Dataset License
Semantic Scholar is a free, AI-powered research tool for scientific literature, based at the Allen Institute for AI.

Dein Browser wird nicht mehr unterstützt. Aktualisiere ihn, um YouTube und unsere neuesten Funktionen optimal nutzen zu können. Weitere Informationen

Lesbische Fickspiele im Cabriolet
Geiles Fotzenfingern im Büro
Asyalı Pornosu 2021

Zooporu

Report Page